RSSDepartments

Hot Topics in Multiple Sclerosis

Hot Topics in Multiple Sclerosis

| June 1, 2018 | 0 Comments

Click the cover below to access the digital editions of Hot Topics in Multiple Sclerosis! June 2018 March 2018 December 2017 November 2017

Continue Reading

Editorial Message and Issue Highlights–Vol. 15, No. 5–6, May-June 2018

Editorial Message and Issue Highlights–Vol. 15, No. 5–6, May-June 2018

| May 1, 2018 | 0 Comments

Dear Colleagues: Welcome to the May–June 2018 issue of Innovations in Clinical Neuroscience (ICNS). We start the issue with a timely review article by Touma and Scarff titled, “Valbenazine and Deutetrabenazine for Tardive Dyskinesia (TD).” Here, the authors discuss the two drugs, which were recently approved by the United States Food and Drug Administration (FDA) […]

Continue Reading

Atrial Fibrillation and Injected Aripiprazole: A Case Report

Atrial Fibrillation and Injected Aripiprazole: A Case Report

| May 1, 2018 | 0 Comments

by Anthi Stefatos, MD; Julie N. Ha, PharmD; Adrian Baranchuk MD; Ross J. Baldessarini, MD; and Gustavo H. Vázquez MD, PhD Drs. Stefatos and Ha are with the Department of Psychiatry at Queens University in Kingston, Ontario, Canada. Dr. Baranchuk is with the Department of Medicine at Queens University in Kingston, Ontario, Canada. Dr. Baldessarini […]

Continue Reading

Development of a Behavioral Health Stigma Measure and Application of Machine Learning for Classification

Development of a Behavioral Health Stigma Measure and Application of Machine Learning for Classification

| May 1, 2018 | 0 Comments

by Farah Tokmic, PhD; Mirsad Hadzikadic, PhD; James R. Cook, PhD; and Oleg V. Tcheremissine, MD Drs. Tokmic and Hadzikadic are with the Department of Software & Information Systems at the University of North Carolina, in Charlotte, North Carolina. Dr. Cook is with the Department of Psychology at the University of North Carolina, in Charlotte, […]

Continue Reading

Delirium and Psychotic Symptoms Associated with Hyperglycemia in a Patient with Poorly controlled Type 2 Diabetes Mellitus

Delirium and Psychotic Symptoms Associated with Hyperglycemia in a Patient with Poorly controlled Type 2 Diabetes Mellitus

| May 1, 2018 | 0 Comments

by Rui Lopes, MD, and Bernardo Dias Pereira, MD Dr. Lopes is with the Faculty of Medicine at the University of Porto in Porto, Portugal. Dr. Pereira is with the Department of Endocrinology and Nutrition at the Hospital do Divino Espírito Santo de Ponta Delgada in Azores, Portugal, and the Pre-clinical Section of the Medicine […]

Continue Reading

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials

| May 1, 2018 | 0 Comments

by David V. Sheehan, MD, MBA; Maria Gasior, MD, PhD; Susan L. McElroy, MD; Jana Radewonuk, MSc; Barry K. Herman, MD, MMM; and James Hudson, MD, ScD Dr. Sheehan is with the University of South Florida College of Medicine in Tampa, Florida. Drs. Herman and Gasior and Ms. Radewonuk are formerly affiliated with Shire Pharmaceuticals […]

Continue Reading

Combination Phentermine–Topiramate Extended Release for the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study

Combination Phentermine–Topiramate Extended Release for the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study

| May 1, 2018 | 0 Comments

by Anna I. Guerdjikova, PhD, LISW; Stephanie Williams, MS; Thomas J. Blom, MS; Nicole Mori, CNP; and Susan L. McElroy, MD Drs. Guerdjikova and McElroy and Ms. Mori are with the Lindner Center of HOPE in Mason, Ohio, and the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati College of Medicine in […]

Continue Reading

Valbenazine and Deutetrabenazine  for Tardive Dyskinesia

Valbenazine and Deutetrabenazine for Tardive Dyskinesia

| May 1, 2018 | 0 Comments

by Katie T. B. Touma, PharmD, BCPP, BCPS, and Jonathan R. Scarff, MD Dr. Touma is with the William Jennings Bryan Dorn VA Medical Center Community-based Outpatient Clinic in Anderson, South Carolina. Dr. Scarff is with the Department of Behavioral Health at Kenner Army Health Clinic in Fort Lee, Virginia. Innov Clin Neurosci. 2018;15(5–6):13–16 Funding: […]

Continue Reading

Risk Management: Lessons to Be Learned: A Review of Post-suicide Malpractice Lawsuits

Risk Management: Lessons to Be Learned: A Review of Post-suicide Malpractice Lawsuits

| May 1, 2018 | 0 Comments

by Ann Mcnary, JD Ms. McNary is Senior Risk Manager at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures: Ms. McNary is an employee at PRMS, Inc. This ongoing column is dedicated to providing information to our readers on managing legal risks associated with medical practice. […]

Continue Reading